Compare CHT & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHT | A |
|---|---|---|
| Founded | 1996 | 1999 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Telecommunications | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.8B | 39.8B |
| IPO Year | 2003 | 1999 |
| Metric | CHT | A |
|---|---|---|
| Price | $42.87 | $112.87 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $161.06 |
| AVG Volume (30 Days) | 148.1K | ★ 2.3M |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | ★ 3.03% | 0.88% |
| EPS Growth | N/A | ★ 3.16 |
| EPS | N/A | ★ 1.07 |
| Revenue | N/A | ★ $4,472,000,000.00 |
| Revenue This Year | $5.31 | $8.42 |
| Revenue Next Year | $3.16 | $6.12 |
| P/E Ratio | ★ $26.66 | $107.91 |
| Revenue Growth | N/A | ★ 6.43 |
| 52 Week Low | $37.03 | $96.43 |
| 52 Week High | $47.03 | $160.27 |
| Indicator | CHT | A |
|---|---|---|
| Relative Strength Index (RSI) | 51.76 | 27.75 |
| Support Level | $41.71 | $111.98 |
| Resistance Level | $43.89 | $122.91 |
| Average True Range (ATR) | 0.79 | 2.90 |
| MACD | -0.06 | -0.30 |
| Stochastic Oscillator | 49.73 | 2.67 |
Chunghwa Telecom Co Ltd is Taiwan's integrated telecom operator, providing fixed-line, wireless, and Internet and data services. The company segment consists of Consumer Business, Enterprise Business, International Business, and Others. The company generates the majority of its revenue from the Consumer Business segment. The consumer Business segment generates revenue from Mobile services, Fixed-line services, Sales, and others.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.